Novelix Pharmaceuticals Limited (BOM:536565)

Market Cap	1.10B +968.5%
Revenue (ttm)	1.28B +1,084.2%
Net Income	18.06M +802.3%
EPS	1.20 +458.7%
Shares Out	17.62M
PE Ratio	52.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,968
Average Volume	9,043
Open	62.58
Previous Close	62.58
Day's Range	58.30 - 63.20
52-Week Range	25.35 - 70.16
Beta	0.39
RSI	54.44
Earnings Date	Feb 12, 2026

About Novelix Pharmaceuticals

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1994
• Employees: 8
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 536565

Financial Performance

In fiscal year 2025, Novelix Pharmaceuticals's revenue was 307.33 million, an increase of 578.26% compared to the previous year's 45.31 million. Earnings were 845,200, an increase of 711.76%.